Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 183 results
  • Sort by Sort ascending
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location

A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis

Diffuse Cutaneous Systemic Sclerosis Phase2 Argentina
Austria
Belgium
Brazil
China
Colombia
France
Germany
Greece
Hungary
India
Italy
Mexico
Poland
Portugal
South Korea
Spain
Taiwan
Thailand
Turkey (Türkiye)
United Kingdom
United States
Vietnam
View All

A 24-week rPMS Study in Real-world Setting for Enerzair

Asthma South Korea

Long Term Observational Study to Collect in a Real-world populatIon Data on the Treatment Pattern of secukinumAb in Adult Patients With Moderate to Severe Hidradenitis Suppurativa.

Hidradenitis Suppurativa Germany

Migraine Survey in Gulf Region

Migraine United Arab Emirates

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Glycopyrronium (Bromide) in Children (6 to Less Than 12 Years) With Asthma

Asthma Phase2 Bulgaria
Colombia
Guatemala
Hungary
Poland
South Africa
Spain
United Kingdom
View All

A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy

Primary IgA Nephropathy Phase3 Argentina
Australia
Belgium
Brazil
China
Colombia
Czechia
Denmark
France
Germany
Hong Kong
Hungary
India
Israel
Italy
Japan
Malaysia
Mexico
Netherlands
Singapore
Slovenia
South Korea
Spain
Sweden
Taiwan
Thailand
Turkey (Türkiye)
United Kingdom
United States
View All

Long-term Follow-up of Patients With Spinal Muscular Atrophy Treated With OAV101 in Clinical Trials

Spinal Muscular Atrophy (SMA) Phase3 Australia
Belgium
Canada
China
Denmark
France
Italy
Japan
Malaysia
Netherlands
Saudi Arabia
Singapore
Spain
Taiwan
Thailand
United Kingdom
United States
Vietnam
View All

Study of PIT565 in Relapsed and/or Refractory B-cell Malignancies

B-cell Non-Hodgkin Lymphoma (B-NHL), B-cell Acute Lymphoblastic Leukemia (B-ALL) Phase1 Belgium
China
France
Israel
Italy
Japan
Singapore
Spain
United States
View All

A Study of Ribociclib in Combination With Hormonal Therapy in HR+/HER2- Advanced or Metastatic Breast Cancer

Breast Cancer Jordan
Oman
Saudi Arabia
United Arab Emirates
View All

Phase 2b Study to Investigate the Safety and Efficacy of TIN816 in Sepsis-associated Acute Kidney Injury (CLEAR-AKI)

Acute Kidney Injury Due to Sepsis Phase2 Argentina
Australia
Austria
Belgium
Brazil
Canada
China
France
Germany
Hungary
India
Italy
Japan
South Africa
Spain
Thailand
United Kingdom
United States
View All